3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Phase 1
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
NIH
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
1883
Carcinoma, Non-Small-Cell Lung
1345
Prostatic Neoplasms
980
Colorectal Neoplasms
848
Multiple Myeloma
740
Leukemia, Myeloid, Acute
725
Neoplasms
689
Lung Neoplasms
678
Neoplasm Metastasis
642
Lymphoma
579
Carcinoma, Hepatocellular
571
Pancreatic Neoplasms
566
Stomach Neoplasms
522
Leukemia
511
Recurrence
490
Leukemia, Lymphocytic, Chronic, B-Cell
459
Precursor Cell Lymphoblastic Leukemia-Lymphoma
452
Melanoma
450
Lymphoma, Non-Hodgkin
442
Ovarian Neoplasms
426
Lymphoma, Large B-Cell, Diffuse
422
Myelodysplastic Syndromes
416
Squamous Cell Carcinoma of Head and Neck
415
Head and Neck Neoplasms
402
Brain Neoplasms
402
Rectal Neoplasms
395
Glioblastoma
374
Carcinoma, Renal Cell
349
Hodgkin Disease
338
Lymphoma, Follicular
336
Interventions
Triamcinolone Acetonide
1
TH 302
1
Injections, Intramuscular
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
OTHER
×
Castration Resistant Prostate Cancer
×
Clear all
NCT06836726
2026-01-28
EVO
University Health Network, Toronto
Phase 2
Not yet recruiting
35 enrolled
NCT07161778
2025-09-09
TRICREST
Barts & The London NHS Trust
Phase 2
Completed
55 enrolled